Epizyme logo

Epizyme

Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease

3

Funding Rounds

$309.5m

Money raised

Overview

Epizyme is a biopharmaceutical company focused on the discovery and development of epigenetic medicines to treat cancer and other disease

Funding

Funding series

Funding Series Analysis

The company Epizyme has raised a total of $309.5m in funding over 3 rounds.

Key Insights:

  • Epizyme , November 2019: $270m
  • Epizyme funding round, June 2011: $7.5m
  • Epizyme Series B round: $32m
Epizyme logo
Epizyme , November 2019 $270m
Epizyme logo
Epizyme funding round, June 2011 $7.5m
Epizyme logo
Epizyme Series B round $32m

Industries

Epizyme is active in the following industries: